Efficacy and safety of Tocilizumab for thyroid eye disease: a systemic review and Meta-analysis.

Saved in:
Bibliographic Details
Title: Efficacy and safety of Tocilizumab for thyroid eye disease: a systemic review and Meta-analysis.
Authors: Lin S; Fujian Provincial Hospital, Shengli Clinical Medical College of Fujian Medical University, Fujian Medical University, Fuzhou, China.; Department of Endocrinology, Fuzhou University Affiliated Provincial Hospital, Fuzhou, China., Ou X; Fujian Provincial Hospital, Shengli Clinical Medical College of Fujian Medical University, Fujian Medical University, Fuzhou, China.; Department of Endocrinology, Fuzhou University Affiliated Provincial Hospital, Fuzhou, China., Cai L; Fujian Provincial Hospital, Shengli Clinical Medical College of Fujian Medical University, Fujian Medical University, Fuzhou, China.; Department of Endocrinology, Fuzhou University Affiliated Provincial Hospital, Fuzhou, China., Huang W; Fujian Provincial Hospital, Shengli Clinical Medical College of Fujian Medical University, Fujian Medical University, Fuzhou, China.; Department of Endocrinology, Fuzhou University Affiliated Provincial Hospital, Fuzhou, China., Wen J; Fujian Provincial Hospital, Shengli Clinical Medical College of Fujian Medical University, Fujian Medical University, Fuzhou, China. junpingwen@163.com.; Department of Endocrinology, Fuzhou University Affiliated Provincial Hospital, Fuzhou, China. junpingwen@163.com.
Source: Journal of endocrinological investigation [J Endocrinol Invest] 2025 Sep; Vol. 48 (9), pp. 1951-1965. Date of Electronic Publication: 2025 Apr 30.
Publication Type: Journal Article; Meta-Analysis; Systematic Review
Journal Info: Publisher: Springer Country of Publication: Italy NLM ID: 7806594 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1720-8386 (Electronic) Linking ISSN: 03914097 NLM ISO Abbreviation: J Endocrinol Invest Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1720-8386
DOI:10.1007/s40618-025-02595-4